Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 80/100

Failure Rate

33.3%

1 terminated/withdrawn out of 3 trials

Success Rate

0.0%

-86.5% vs industry average

Late-Stage Pipeline

33%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 2
2(66.7%)
Phase 3
1(33.3%)
3Total
Phase 2(2)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT04888741Phase 2Recruiting

Methods of T Cell Depletion Trial (MoTD)

Role: collaborator

NCT05539625Phase 2Withdrawn

Mini-MARVEL - Mitochondrial Antioxidant Therapy in Ulcerative Colitis

Role: collaborator

NCT06519422Phase 3Not Yet Recruiting

Tranexamic Acid for Anaemia Trial

Role: collaborator

All 3 trials loaded